Page last updated: 2024-08-22

c.i. direct blue 1 and Alzheimer Disease

c.i. direct blue 1 has been researched along with Alzheimer Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cui, W; Tao, T; Wang, C; Wang, Q; Xuan, Z; Yan, S; Yang, M	1

Other Studies

1 other study(ies) available for c.i. direct blue 1 and Alzheimer Disease

Article	Year
CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells. International immunopharmacology, 2020, Volume: 81 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Cell Line; Cognitive Dysfunction; Cytokines; Humans; Inflammation Mediators; Mice; Mice, Inbred ICR; Microglia; Neurogenic Inflammation; Neurons; NF-kappa B; Nitric Oxide Synthase Type II; NLR Family, Pyrin Domain-Containing 3 Protein; Trypan Blue	2020

Article

Year

CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells.

International immunopharmacology, 2020, Volume: 81

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Cell Line; Cognitive Dysfunction; Cytokines; Humans; Inflammation Mediators; Mice; Mice, Inbred ICR; Microglia; Neurogenic Inflammation; Neurons; NF-kappa B; Nitric Oxide Synthase Type II; NLR Family, Pyrin Domain-Containing 3 Protein; Trypan Blue

2020